Management to Hold Conference Call at 10:00 a.m. EDT
TEL AVIV, Israel, May 17, 2023 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ:BLRX) (TASE:BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, announced today that it will release its unaudited financial results for the quarter ended March 31, 2023 on Wednesday, May 24, 2023, before the U.S. markets open.
Read more at prnewswire.com